Antiretroviral Therapy Current Events | Antiretroviral Therapy News | 2
|
| Page
2 of
36 |
712 Results |
|
|
|
Sort By:
Page Views | Date |
Anti-HIV Therapy Boosts Life Expectancy
The life expectancy for patients with human immunodeficiency virus (HIV) has increased by more than 13 years since the late 1990s thanks to advancements in antiretroviral therapy, according to researchers at the University of Alabama at Birmingham (UAB) and Simon Fraser University in Vancouver, British Columbia. view more (2008-07-28)
HIV drug resistance is increasing in the UK
The prevalence of transmitted HIV drug resistance in the United Kingdom is increasing, according to a study in this week's BMJ. This finding emphasises the urgent need for new approaches to encourage safer sexual behaviour. A total of 69 patients infected with HIV between June 1994 and August 2000 were evaluated for resistance within 18 months of... view more... (2001-05-02)
Aids : Effectiveness of antiretroviral therapy demonstrated in Africa
Tritherapies using antiretroviral drugs have proved their worth in industrialized countries in the fight against Aids. However, in Sub-Saharan Africa, where 70 % of people infected with HIV live, access to such treatments is extremely limited. High cost, complicated procedures, combined with inadequate infrastructures for following up patients or... view more... (2002-06-27)
Antiretroviral Therapy Around Childbirth Reduces Risk Of Mother-To-Child HIV-1 Transmission (pp 1168, 1178)
Antiretroviral therapy given to women before, during, and after childbirth could be beneficial in reducing mother-to-child HIV-1 transmission in the first few weeks after delivery, suggest authors of a study in this week's issue of THE LANCET. However, this short-term benefit could be compromised unless new interventions are identified to prevent... view more... (2002-04-04)
Timely Antiretroviral Therapy Essential For Best Prognosis In People With HIV-1 Infection (p 119)
Authors of an international study in this week's issue of THE LANCET highlight how timely treatment with highly-active antiretroviral therapy (HAART) can substantially improve the three-year prognosis for people with HIV-1 infection. HAART became widespread in more-developed countries in 1996. However, there is insufficient data from individual... view more... (2002-07-10)
U of M study shows why treatment isn't effective for HIV
University of Minnesota researchers have answered a key question as to why antiretroviral therapy isn't effective in restoring immunity in HIV-infected patients. view more (2008-08-06)
Important factors in compliance with HIV regimens identified; and more
Adherence to HIV medications is the greatest predictor of death. How well patients with HIV adhere to their regimens of highly active antiretroviral therapy (HAART) medication depends on a variety of factors, either positive or negative, many of which are common to patients around the world. view more (2006-11-21)
To slow AIDS in Russia, treat HIV-positive addicts, Stanford study says
The key to combating AIDS in Russia may be to treat HIV-infected drug users. A new model estimating the spread of HIV in Russia suggests that treating injection drug users with antiretroviral medication will slow transmission of the virus among the general population. view more (2006-11-10)
When should children infected with HIV start medication
The advent of effective medications for treating HIV dramatically improved the outlook for both adults and children infected with HIV who had access to treatment, but the optimal timing for starting treatment remains controversial, particularly in children. view more (2008-03-25)
Resistance to anti-HIV drugs in Uganda developed due to drug supply problems
Some HIV-infected patients in Uganda who self-paid for their antiretroviral medications experienced interruptions in drug supply due to either financial demands or supply logistical disruptions. view more (2007-04-23)
Study Suggests Potential Of Low-cost Options For Monitoring Disease Status In Hiv-1-Infected Children In Less-developed Countries (pp 1597, 1625)
Authors of a research letter in this week's issue of THE LANCET highlight how assessment of total blood lymphocyte count and albumen concentrations could have potential as low-cost alternatives in assessing the disease status of HIV-1-infected children in less-developed countries. The cost of laboratory analysis of CD4 lymphocyte count and... view more... (2003-11-12)
Markers of inflammation and blood-clotting tied to hazards of intermittent HIV treatment
Episodic treatment of HIV/AIDS with antiretroviral drugs increases the overall risk of death when compared with continuous antiretroviral treatment (ART), but the reasons why have been unknown. view more (2008-10-22)
Gains in access to antiretroviral treatment come with some costs
In this week's PLoS Medicine magazine, Yibeltal Assefa, from the National HIV/AIDS Prevention and Control Office in Addis Ababa, and colleagues describe the successes and challenges of the scale-up of antiretroviral treatment (ART) across Ethiopia. view more (2009-04-28)
FEMALE GENITAL SHEDDING OF HIV-1 POSES INFECTION RISK (pp 1564, 1593)
A study in this week's issue of THE LANCET suggests that heterosexual women with HIV-1-including those who have had successful antiretroviral therapy-are at risk of transmitting HIV to their sexual partners and newborn infants as a result of viral shedding in the genital tract. Plasma HIV-1 RNA concentration has been the best predictor for risk of... view more... (2001-11-07)
Ultra deep sequencing identifies HIV drug resistance at early stage
Rare, previously undetectable drug-resistant forms of HIV have been identified by Yale School of Medicine researcher Michael Kozal, M.D., using an innovative genome sequencing technology that quickly detects rare viral mutations. view more (2007-06-18)
Well-armed immune cells help long-term nonprogressors contain HIV
To help develop an effective HIV vaccine, researchers are trying to better understand how the immune systems of a small minority of HIV-infected people known as long-term non-progressors (LTNPs) contain the virus naturally. view more (2008-12-05)
International panel updates treatment guidelines for HIV infection
An evaluation of recent data has led to an update in the guidelines and recommendations for antiretroviral treatment of adult human immunodeficiency virus (HIV) infection, according to an article in the August 6 issue of JAMA, a theme issue on HIV/AIDS. view more (2008-08-04)
Highly active antiretroviral therapy of similar benefit for HIV-infected injection drug users
Contrary to the belief that HIV-infected injection drug users (IDUs) receive less benefit from highly active antiretroviral therapy (HAART), new research finds little difference in the survival rate between IDUs and non-IDUs after 4-5 years of receiving HAART. view more (2008-08-04)
Treating HIV-infected infants early helps them live longer
Hundreds of thousands of babies around the world are born each year with HIV--more than half a million in 2006 alone. view more (2007-07-25)
Combination anti-retroviral therapies associated with reduced infections in HIV-infected children
Since the introduction of highly active antiretroviral therapies, there has been a substantial reduction of opportunistic infections and other infections in HIV-infected children, such as pneumonia and tuberculosis. view more (2006-07-19)
|
|
| Page
2 of
36 |
712 Results |
|
|
|
Sort By:
Page Views | Date |
|
